| Primary |
|
|
| Secondary |
| Renal Transplant |
34.7% |
| Drug Use For Unknown Indication |
10.1% |
| Hypertension |
7.9% |
| Acute Lymphocytic Leukaemia |
6.9% |
| Chronic Obstructive Pulmonary Disease |
6.9% |
| Product Used For Unknown Indication |
4.1% |
| Prophylaxis Against Transplant Rejection |
4.0% |
| Cardiac Failure |
2.9% |
| Cough |
2.2% |
| Prophylaxis |
2.2% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Recurrent |
2.0% |
| Non-hodgkin's Lymphoma |
2.0% |
| Pain |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Infection |
1.8% |
| Prophylactic Chemotherapy |
1.8% |
| Anaesthesia |
1.6% |
| Liver Transplant |
1.6% |
| Pneumonia |
1.6% |
| Bronchospasm |
1.5% |
|
| Urosepsis |
14.6% |
| Post Procedural Haemorrhage |
10.2% |
| Stomatitis |
7.0% |
| Toxic Epidermal Necrolysis |
7.0% |
| Urinary Tract Infection |
7.0% |
| Sepsis |
6.4% |
| Stevens-johnson Syndrome |
5.7% |
| Kidney Transplant Rejection |
4.5% |
| Renal Failure Acute |
4.5% |
| Subcutaneous Abscess |
4.5% |
| Therapeutic Agent Toxicity |
4.5% |
| Ureteral Stent Insertion |
3.8% |
| Lymphocele |
3.2% |
| Respiratory Failure |
3.2% |
| Cytomegalovirus Infection |
2.5% |
| Impaired Healing |
2.5% |
| Transplant Failure |
2.5% |
| Ureteric Stenosis |
2.5% |
| Colitis |
1.9% |
| Neutropenia |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.5% |
| Drug Use For Unknown Indication |
17.8% |
| Renal Transplant |
12.4% |
| Rheumatoid Arthritis |
10.8% |
| Crohn's Disease |
5.4% |
| Hypertension |
4.7% |
| Prophylaxis |
4.0% |
| Prophylaxis Against Transplant Rejection |
3.3% |
| Premedication |
3.1% |
| Neuralgia |
2.6% |
| Pain |
2.6% |
| Osteoporosis |
2.1% |
| Liver Transplant |
1.8% |
| Colitis Ulcerative |
1.6% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Diabetes Mellitus |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Non-hodgkin's Lymphoma |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Bronchitis |
1.2% |
|
| Vomiting |
11.8% |
| Renal Failure Acute |
9.2% |
| Neutropenia |
5.9% |
| Thrombocytopenia |
5.9% |
| Death |
5.2% |
| Urticaria |
5.2% |
| Crohn's Disease |
4.6% |
| Pyrexia |
4.6% |
| Respiratory Moniliasis |
4.6% |
| Urinary Tract Infection |
4.6% |
| Withdrawal Syndrome |
4.6% |
| Cerebrovascular Accident |
3.9% |
| Renal Failure |
3.9% |
| Respiratory Failure |
3.9% |
| Septic Shock |
3.9% |
| Surgery |
3.9% |
| Toxic Epidermal Necrolysis |
3.9% |
| Weight Decreased |
3.9% |
| Blood Creatinine Increased |
3.3% |
| Cytomegalovirus Infection |
3.3% |
|
| Interacting |
| Hypertension |
22.7% |
| Glomerulonephritis |
13.6% |
| Chronic Obstructive Pulmonary Disease |
6.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.8% |
| Urticaria |
6.8% |
| Erysipelas |
5.7% |
| Hyperlipidaemia |
4.5% |
| Metabolic Acidosis |
4.5% |
| Oedema Peripheral |
4.5% |
| Prophylaxis |
4.5% |
| Renal Impairment |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Atrial Fibrillation |
2.3% |
| Copd |
2.3% |
| Dyslipidaemia |
2.3% |
| Granuloma |
2.3% |
| Drug Use For Unknown Indication |
1.1% |
|
| Lip Swelling |
37.5% |
| Drug Interaction |
12.5% |
| Enterocolitis Infectious |
12.5% |
| Pneumonia |
12.5% |
| Renal Failure Acute |
12.5% |
| Meningitis Cryptococcal |
6.3% |
| Pneumonia Legionella |
6.3% |
|
